中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
15期
195-196
,共2页
白细胞输血%大剂量输血%临床分析
白細胞輸血%大劑量輸血%臨床分析
백세포수혈%대제량수혈%림상분석
Leukoreduction blood transfusion%Large amount of blood transfusion%Clinical study
目的:针对去白细胞输血和常规输血患者大剂量输血应用的疗效进行分析。方法选取于2012年4月~2014年4月期间在我院接受治疗的120例需要大剂量输血的患者,将患者随机分为观察组和对照组,每组各60例,观察组采用去白细胞输血,对照组采用常规输血,对两组输血患者输血后不良发生率进行对比。结果观察组在采用去白细胞输血后产生的不良反应率为6.7%,对照组在采用常规输血后产生的不良反应率为23.3%,观察组显著低于对照组,差异显著,有统计学意义(P<0.05)。结论去白细胞输血可以有效降低大剂量输血引起的不良反应,可以有效改善患者的内脏功能,值得临床广泛推荐。
目的:針對去白細胞輸血和常規輸血患者大劑量輸血應用的療效進行分析。方法選取于2012年4月~2014年4月期間在我院接受治療的120例需要大劑量輸血的患者,將患者隨機分為觀察組和對照組,每組各60例,觀察組採用去白細胞輸血,對照組採用常規輸血,對兩組輸血患者輸血後不良髮生率進行對比。結果觀察組在採用去白細胞輸血後產生的不良反應率為6.7%,對照組在採用常規輸血後產生的不良反應率為23.3%,觀察組顯著低于對照組,差異顯著,有統計學意義(P<0.05)。結論去白細胞輸血可以有效降低大劑量輸血引起的不良反應,可以有效改善患者的內髒功能,值得臨床廣汎推薦。
목적:침대거백세포수혈화상규수혈환자대제량수혈응용적료효진행분석。방법선취우2012년4월~2014년4월기간재아원접수치료적120례수요대제량수혈적환자,장환자수궤분위관찰조화대조조,매조각60례,관찰조채용거백세포수혈,대조조채용상규수혈,대량조수혈환자수혈후불량발생솔진행대비。결과관찰조재채용거백세포수혈후산생적불량반응솔위6.7%,대조조재채용상규수혈후산생적불량반응솔위23.3%,관찰조현저저우대조조,차이현저,유통계학의의(P<0.05)。결론거백세포수혈가이유효강저대제량수혈인기적불량반응,가이유효개선환자적내장공능,치득림상엄범추천。
Objective Application effects of leukoreduction and routine blood transfusion patients who are in need of large amount of blood transfusion are to be studied.Methods Choose 120 patients who are in need of large amount of blood transfusion and treated in hospital from April 2012 to April 2014 and separate them into study group and control group at random with 60 patients in each group; patients in study group are given leukoreduction blood transfusion and patients in control group are given routine blood transfusion, then compare patients’ side-effect incidence after blood transfusion between two groups.Results Patients’ side-effect incidence of leukoreduction blood transfusion in study group is 6.7%, while patients’ side-effect incidence of routine blood transfusion in control group is 23.3%, side-effect incidence in study group is much lower than that in control group, there is a treatment differential between two groups and such a differential has statistic value (P < 0.05). Conclusion Leukoreduction blood transfusion is conducive to reducing patients’ side-effect incidence and improving patients’ visceral function. Thus, such a treatment method is quite worthwhile to be applied clinicaly.